XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
XBiotech's enterprise value was -$50.08M on Nov 11, 2026, against -$78.16M a year earlier. Over the last 5 years it ranged from -$121.48M to $99.45M, with a median of -$59.55M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$50.08M | – |
| 2025 | Dec 31, 2025 | -$74.50M | – |
| 2024 | Dec 31, 2024 | -$62.72M | – |
| 2023 | Dec 29, 2023 | -$80.44M | – |
| 2022 | Dec 30, 2022 | -$113.26M | -213.9% |
| 2021 | Dec 31, 2021 | $99.45M | -54.6% |
| 2020 | Dec 31, 2020 | $218.93M | -69.9% |
| 2019 | Dec 31, 2019 | $726.17M | +350.7% |
| 2018 | Dec 31, 2018 | $161.12M | +60.1% |
| 2017 | Dec 29, 2017 | $100.65M | -64.3% |
| 2016 | Dec 30, 2016 | $281.54M | +16.0% |
| 2015 | Dec 31, 2015 | $242.74M | – |
See a number that looks wrong?